Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapinarof Cream for Moderate to Severe Atopic Dermatitis in Children and Adults
NCT05014568Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Sep 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of tapinarof in atopic dermatitis (AD), sponsored by Organon & Co.. Started Sep 2021; status: completed.
02
Drugs
tapinarof
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT05014568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05014568.